Canada markets closed

Janux Therapeutics, Inc. (JANX)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
47.39+0.29 (+0.62%)
At close: 04:00PM EDT
47.50 +0.11 (+0.23%)
After hours: 07:30PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
8,083
8,083
8,612
3,637
0
Operating Expenses
Research Development
54,922
54,922
53,441
26,237
3,041
Selling General and Administrative
26,140
26,140
22,262
10,329
1,802
Total Operating Expenses
81,062
81,062
75,703
36,566
4,843
Operating Income or Loss
-72,979
-72,979
-67,091
-32,929
-4,843
Interest Expense
-
-
-
0
206
Total Other Income/Expenses Net
-
-
-
-
-1,735
Income Before Tax
-58,293
-58,293
-63,059
-32,672
-6,784
Income from Continuing Operations
-58,293
-58,293
-63,059
-32,672
-6,784
Net Income
-58,293
-58,293
-63,059
-32,672
-6,784
Net Income available to common shareholders
-58,293
-58,293
-63,059
-32,672
-6,784
Basic EPS
-1.52
-
-1.52
-1.39
-0.54
Diluted EPS
-1.52
-
-1.52
-1.39
-0.54
Basic Average Shares
41,470
-
41,470
23,530
12,473
Diluted Average Shares
41,470
-
41,470
23,530
12,473